IL17A and colitis: Rather than rendering the mice vulnerable to C. rodentium, mice treated with M(IL4)s showed enhanced protection against infection and less colonic histopathology that correlated with reduced mRNA expression of IL-22, IL-17 and IFNγ, hallmarks of C. rodentium-colitis.